Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics.

Saved in:
Bibliographic Details
Title: Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics.
Authors: Serumula W; Department of Nuclear Medicine, School of Health Sciences, University of KwaZulu-Natal, Durban 4058, South Africa., Pillay V; Department of Nuclear Medicine, School of Health Sciences, University of KwaZulu-Natal, Durban 4058, South Africa., Hadebe B; Department of Nuclear Medicine, School of Health Sciences, University of KwaZulu-Natal, Durban 4058, South Africa., Vorster M; Department of Nuclear Medicine, School of Health Sciences, University of KwaZulu-Natal, Durban 4058, South Africa.
Source: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2025 Apr 03; Vol. 18 (4). Date of Electronic Publication: 2025 Apr 03.
Publication Type: Journal Article; Review
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1424-8247
DOI:10.3390/ph18040522